EINDHOVEN, The Netherlands and
NEW YORK, March 24, 2015 /CNW/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today
announced a joint development agreement with the Mount Sinai Health
System, an integrated health system in New York, to create a state-of-the-art digital
image repository of patient tissue samples and innovative data
analytics to pursue the discovery of new tissue-based tests and
unlock pathology data. The collaboration aims to advance clinical
research and ultimately enable better care for complex diseases,
including cancer.
Pathology, including the examination of patient tissue samples,
is one of the corner stones of modern medicine. The Mount Sinai
Health System comprises seven hospital campuses serving
approximately 170,000 inpatients and 2.6 million outpatients
annually. Over the years, these sites have collectively stored
hundreds of thousands of tissue samples in the form of glass tissue
slides. Philips and Mount Sinai
will now start to create a comprehensive digital image repository
containing the digital scans of all these glass tissue slides.
Ultimately, these data will be made accessible to researchers. By
integrating, analyzing and presenting the data available from whole
slide pathology images, clinical laboratory services, genetic
analysis, radiology, and surgical and molecular pathology, Philips
and Mount Sinai believe the unique
insights obtained will enable the development of predictive
analytics to help personalize patient care.
"The digitization of pathology gives us the unprecedented
opportunity to access vast amounts of unlocked data and view it
within the context of other images, results and clinical
information," said Frans van Houten,
CEO Royal Philips. "It is our vision
that our improved understanding of these data will help us enable
better, more individualized care with greater confidence."
"This collaboration with Philips has the potential to help drive
a new paradigm in healthcare that includes the optimization of
treatment efficacy and superior clinical outcomes," said Dr.
Carlos Cordon-Cardo M.D., Ph.D.,
Chairman of the Department of Pathology at the Mount Sinai Health
System. "Our ultimate goal with this initiative is to translate
data into knowledge to maximize personalized patient
management."
Mount Sinai is committed to
partnering with industry to develop innovative therapies and
diagnostics that improve the lives of patients worldwide. The terms
of this collaboration agreement were managed by Mount Sinai
Innovation Partners, the technology development and
commercialization group for the Mount Sinai Health System.
For further information, please contact:
Philips:
Hans
Driessen
Philips Digital Pathology Solutions
Tel: +31 6 10 610 417
E-mail: hans.driessen@philips.com
Steve
Klink
Philips Group Communications
Tel.: +31 6 1088 8824
E-mail: steve.klink@philips.com
Mount Sinai Health System:
Sid Dinsay
Mount Sinai Health System Press Office
Tel: +1 212 241 9200
E-mail: sid.dinsay@mountsinai.org
About the Mount Sinai Health System
The Mount Sinai
Health System is an integrated health system committed to providing
distinguished care, conducting transformative research, and
advancing biomedical education. Structured around seven member
hospital campuses and a single medical school, the Health System
has an extensive ambulatory network and a range of inpatient and
outpatient services—from community-based facilities to tertiary and
quaternary care.
The System includes approximately 6,600 primary and specialty
care physicians, 12-minority-owned free-standing ambulatory surgery
centers, over 45 ambulatory practices throughout the five boroughs
of New York City, Westchester, and Long Island, as well as 31 affiliated
community health centers. Physicians are affiliated with the Icahn
School of Medicine at Mount Sinai,
which is ranked among the top 20 medical schools both in National
Institutes of Health funding and by U.S. News & World
Report. For more information, visit http://www.mountsinai.org, or
find Mount Sinai on Facebook,
Twitter and YouTube.
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and
Lighting. Headquartered in the
Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately
105,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
Photo - http://photos.prnewswire.com/prnh/20150324/184024
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-and-mount-sinai-health-system-collaborate-to-advance-clinical-research-through-new-digital-pathology-database-and-analytics-300055011.html
SOURCE Royal Philips